Abstract
The thermophilic eubacterium Bacillus stearothermophilus was used as a model to study the effects of amiodarone (2-butyl-3-[3′,5′diido-4′α-diethyl-aminoethoxybenzoyl]-benzofuran) in lipid organization and in bacterial growth. Effects on the structural order of lipids were assessed by fluorescence polarization of 1,6-diphenyl-1,3,5-hexatriene (DPH), probing the bilayer core, and of the propionic acid derivative 3-[p-(6-phenyl)-1,3,5-hexatrienyl] phenylpropionic acid (DPH-PA), probing the outer regions of the bilayer. Amiodarone fluidizes bacterial polar lipid bilayers for temperatures below the phase transition midpoint, and orders the fluid phase of the bacterial polar lipids, as evaluated by DPH and DPH-PA. The ordering and disordering effects, which are concentration dependent, are more extensive when detected by DPH relative to DPH-PA. Growth studies performed in parallel revealed that amiodarone inhibits bacterial growth as a function of concentration. Amiodarone concentrations in the range from 1 to 2.5 µM increased the lag time, decreased the specific growth rate, and decreased the final cell density. Furthermore, 3 µM amiodarone completely inhibited growth. These in vivo effects of amiodarone can be related to its ability to perturb the phospholipid bilayer structure, whose integrity is essential for cell function, viability, and growth.
Similar content being viewed by others
References
Rosenbourn, M. B., Chiale, P. A., Halpern, M. S., Nau, G. J., Przybylzky, J., Levi, R. J., Lazzari, J. O., and Elizari, M. V. (1976), Am. J. Cardiol. 38, 934–944.
Gill, J., Heel, R. C., and Fitton, A. (1992), Drugs 43, 69–110.
Jendrasiak, G. L., McIntosh, T. J., Ribeiro, A., and Porter, R. S. (1990), Biochim. Biophys. Acta 1024, 19–31.
Trumbore, M., Chester, D. W., Moring, J., Rhodes, D., and Herbette, L. G. (1988), Biophys. J. 54, 535–543.
Chatelain, P., Ferreira, J., Laruel, R., and Ruysschaert, J. M. (1986), Biochem. Pharmacol. 35, 3007–3013.
Chatelain P., Brottelle, R., and Laruel, R. (1987), Biochem. Pharmacol. 36, 1564, 1565.
Sautereau, A.-M., Tournaire, C., Suares, M., Tocanne, J. F., and Paillous, N. (1992), Biochem. Pharmacol. 43, 2559–2566.
Antunes-Madeira, M. C., Videira, R. A., Klüppel, M. L. W., and Madeira, V. M. C. (1995), Int. J. Cardiol. 48, 211–218.
Attal, Y., Cao, X. A., Perret, G., and Taillandier, E. (1997), Chem. Pharm. Bull. 45, 1317–1322.
Chatelain, P., Laruel, R., and Gillard, M. (1985), Biochem. Biophys. Res. Commun. 129, 148–154.
Chatelain, P., Laruel, R., Vic, P., and Brotelle, R. (1989), Biochem. Pharmacol. 38, 1231–1239.
Nishimura, M., Follmer, C. H., and Singer, D. H. (1989), J. Pharmacol. Exp. Ther. 251, 650–659.
Fromenty, B., Fish, C., Berson, A., Letteron, P., Larrey, D., and Pessayre, D. (1990), J. Pharmacol. Exp. Ther. 255, 1377–1384.
Watanase, Y., Hara, Y., Tamagawa, M., and Nakaya, H. (1996), J. Pharmacol. Exp. Ther. 279, 617–624.
Card, J. W., Lalonde, B. L., Rafeiro, F., Tam, A. S., Racs, W. J., Brien, J. F., Bray, T. M., and Massey, T. E. (1998), Toxicol. Lett. 98, 41–50.
Gray, D. F., Mihailidon, A. S., Hansen, P. S., Buhagiar, K. A., Bewick, N. L., Rasmussen, H. H., and Wholley, D. W. (1998), J. Pharmacol. Exp. Ther. 284, 75–82.
Silva, M. T., Sousa, J. C. F., Polónia, J. J., and Macedo, P. M. (1979), Y. Bacteriol. 137, 461–468.
Sikkema, J., Poolman, B., Konings, W. N., and De Bont, J. A. M. (1992), J. Bacteriol. 174, 2986–2992.
Sikkema, J., De Bont, J. A. M., and Poolman, B. (1995), Microbiol. Rev. 59, 201–222.
Luxo, C., Jurado, A. S., Custódio, J. B. A., and Madeira, V. M. C. (1996), Toxicol. Vitro 10, 463–471.
Luxo, C., Jurado, A. S., and Madeira, V. M. C. (1998), Biochim. Biophys. Acta 1369, 71–84.
Donato, M. M., Jurado, A. S., Antunes-Madeira, M. C., and Madeira, V. M. C. (1997), Arch. Environ. Contam. Toxicol. 33, 109–116.
Donato, M. M., Jurado, A. S., Antunes-Madeira, M. C., and Madeira, V. M. C. (1997), Arch. Environ. Contam. Toxicol. 33, 341–349.
Donato, M. M., Jurado, A. S., Antunes-Madeira, M. C., and Madeira, V. M. C. (1997), Appl. Environ. Microbiol. 63, 4948–4951.
Kaback, H. R. (1972), Biochim. Biophys. Acta 265, 367–416.
Booth, I. R. (1985), Microbiol. Rev. 49, 359–378.
Stock, J. B., Stock, A. M., and Mottonen, J. M. (1990), Nature 344, 395–400.
Trumpower, B. L. and Gennis, R. B. (1994), Annu. Rev. Biochem. 63, 675–716.
Jurado, A. S., Santana, A. C., Costa, M. S., and Madeira, V. M. C. (1987), J. Gen. Microbiol. 133, 507–513.
Bligh, E. G. and Dyer, W. J. (1959), Can. J. Biochem. Physiol. 37, 911–937.
Bartlett, G. R. (1959), J. Biol. Chem. 234, 466–468.
Böttcher, C. J. F., Van Gent, C. M., and Pries, C. (1961), Anal. Chim. Acta 24, 203, 204.
Shinitzky, M. and Barenholz, Y. (1978), Biochim. Biophys. Acta 515, 367–394.
Litman, B. J. and Barenholz, Y. (1982), Methods Enzymol. 81, 678–685.
Trotter, P. J. and Storch, J. (1989), Biochim. Biophys. Acta 982, 131–139.
Jurado, A. S., Pinheiro, T. J. T., and Madeira, V. M. C. (1991), Arch. Biochem. Biophys. 289, 167–179.
Chefurka, W., Chatelier, R. C., and Sawer, W. H. (1987), Biochim. Biophys. Acta 896, 181–186.
Ferreira, J., Chatelain, P., Caspers, J., and Ruysschaert, J. M. (1987), Biochem. Pharmacol. 36, 4245–4250.
Jain, M. K. and Wu, N. M. (1977), J. Membr. Biol. 34, 157–201.
Cevc, G. (1987), Biochemistry 26, 6305–6310.
Mouritsen, O. G. and Jörgensen, K. (1994), Chem. Phys. Lipids 73, 3–25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosa, S.M.L.J., Antunes-Madeira, M.C., Jurado, A.S. et al. Amiodarone interactions with membrane lipids and with growth of Bacillus stearothermophilus used as a model. Appl Biochem Biotechnol 87, 165–175 (2000). https://doi.org/10.1385/ABAB:87:3:165
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ABAB:87:3:165